South America Allergy Immunotherapy Market
South America Allergy Immunotherapy Market Research Report: By Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy), By Product (Allergen Extracts, Conventional Immunotherapy, Biologics), By Indication (Allergic Rhinitis, Allergic Asthma, Atopic Dermatitis, Food Allergies), By Patient Type (Pediatric, Adult, Geriatric) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Forecast to 2035
Industry Developments
The South America Allergy Immunotherapy Market has recently seen significant developments, influenced by companies such as Stallergenes Greer, Anergis, ImmunoCap, Aimmune Therapeutics, Boehringer Ingelheim, Thermo Fisher Scientific, Mylan, Novartis, ALK Technologies, Merck KGaA, HollisterStier Allergy, Datapharm, and Alk Abello. In May 2023, Stallergenes Greer announced an expansion of its operations in Brazil to enhance its production and distribution capabilities. Additionally, in August 2023, Boehringer Ingelheim launched a new line of allergy immunotherapy products in Argentina, responding to the rising prevalence of allergic conditions in the region. Over the past two years, the market has also witnessed growth, attributed to increased investments and collaborations among the key players. For instance, Aimmune Therapeutics and Merck KGaA revealed a partnership in early 2022 aimed at advancing Research and Development for allergic food therapies in Brazil. The Allergy Immunotherapy Market is projected to expand due to rising awareness of allergies and overall healthcare investment in South America. These developments are indicative of the dynamic and evolving landscape of the allergy treatment sector across the continent.
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 532.0(USD Million) |
| MARKET SIZE 2024 | 571.0(USD Million) |
| MARKET SIZE 2035 | 1250.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.383% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Stallergenes Greer, Anergis, ImmunoCap, Aimmune Therapeutics, Boehringer Ingelheim, Thermo Fisher Scientific, Mylan, Novartis, ALK Technologies, Merck KGaA, HollisterStier Allergy, Datapharm, Alk Abello |
| SEGMENTS COVERED | Type, Product, Indication, Patient Type, Regional |
| KEY MARKET OPPORTUNITIES | Rising prevalence of allergies, Increasing awareness of immunotherapy, Growing investment in healthcare, Innovative treatment options emerging, Expansion of distribution networks |
| KEY MARKET DYNAMICS | increasing allergic conditions prevalence, growing awareness of immunotherapy, advancements in treatment technologies, supportive regulatory environment, rising healthcare expenditure |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
FAQs
What is the projected market size of the South America Allergy Immunotherapy Market by 2035?
The South America Allergy Immunotherapy Market is projected to reach a valuation of 1250.0 USD Million by 2035.
What is the expected CAGR for the South America Allergy Immunotherapy Market from 2025 to 2035?
The market is expected to grow at a CAGR of 7.383% from 2025 to 2035.
Which region holds the largest share in the South America Allergy Immunotherapy Market?
Brazil holds the largest market share, valued at 245.0 USD Million in 2024.
What is the market size for Subcutaneous Immunotherapy in 2024?
Subcutaneous Immunotherapy is valued at 230.0 USD Million in 2024.
Who are the major players in the South America Allergy Immunotherapy Market?
Major players include Stallergenes Greer, Anergis, ImmunoCap, and Boehringer Ingelheim.
How much is the market size for Sublingual Immunotherapy expected to be in 2035?
Sublingual Immunotherapy is expected to reach a market size of 450.0 USD Million by 2035.
What is the projected market size for Oral Immunotherapy by 2035?
Oral Immunotherapy is projected to be valued at 300.0 USD Million by 2035.
How is the South America Allergy Immunotherapy Market segmented by region?
The market is segmented into Brazil, Mexico, Argentina, and the Rest of South America.
What is the expected market size for Mexico in 2024?
Mexico is expected to account for 150.0 USD Million in the Allergy Immunotherapy Market in 2024.
What challenges could impact the growth of the South America Allergy Immunotherapy Market?
Challenges may include regulatory hurdles and varying healthcare access across regions.
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Leave a Comment